ASPI ASP ISOTOPES INC

ASP Isotopes to Provide Quarterly Business Update Call on November 21, 2025 at 8:30am EST

ASP Isotopes to Provide Quarterly Business Update Call on November 21, 2025 at 8:30am EST

WASHINGTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of isotopes for multiple industries, today announced it will hold a quarterly business update conference call and webcast on Friday, November 21, 2025 at 8:30 a.m. (Eastern Time).

Conference Call Information

To participate in this event, please log on or dial in approximately 5 minutes before the beginning of the call.

Webcast Link

Participant Dial-In Details

Date: November 21, 2025

Time: 8:30 a.m. EST

Dial in:

  • USA / International Toll: +1 .646.968.2525
  • USA - Toll-Free: +1.888.596.4144
  • Canada – Toronto: +1.647.495.7514
  • Canada - Toll-Free: +1.888.596.4144

Conference ID: 5073116 and press #

Transcript will be released after the call on the ASPI website.

About ASP Isotopes Inc.

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (“ASP technology”). The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes).

There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. We believe the ASP technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit .

Contacts

Jason Assad– Investor relations

Email: 



EN
17/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ASP ISOTOPES INC

 PRESS RELEASE

ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic ...

ASP Isotopes Announces Establishment of Quantum Leap Energy Strategic Advisory Board, Bolstering its Plans for the Nuclear Fuel Sector Distinguished Nuclear Fuel and Advanced Materials Leaders Appointed as Initial SAB Members DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has formed a Strategic Advisory Board (“SAB)”,...

 PRESS RELEASE

ASP Isotopes Announces Quantum Leap Energy to Establish Global Headqua...

ASP Isotopes Announces Quantum Leap Energy to Establish Global Headquarters in Austin, TX State’s Support of Nuclear Power and Constructive Regulatory Environment to Boost Commercial Pathway for Developer of Advanced Nuclear Fuels DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced its plans for Quantum Leap Energy LLC (“QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, to establish QLE’s new global co...

 PRESS RELEASE

ASP Isotopes Inc. Provides Production Update on the Renergen Helium Pr...

ASP Isotopes Inc. Provides Production Update on the Renergen Helium Project This Production Update reports operational progress since April 2025, following bridge loan funding provided by ASP Isotopes Inc. (“ASPI”) (prior to the completion of ASPI’s acquisition of Renergen), and highlights measurable improvements in drilling execution, gas production, subsurface confidence, and commercial readiness since ASPI involvement. Key highlights include: Investment has augmented existing operational capacity. Management estimates the plant is now processing approximately 60% more gas as a result o...

 PRESS RELEASE

ASP Isotopes Closes Acquisition of Renergen

ASP Isotopes Closes Acquisition of Renergen Combined Company Expected to Become a Global Critical Materials Provider Focused on High-Growth Industries in Isotope and Helium Markets Renergen Expected to Benefit from $750 million of Committed Debt Funding from the U.S. government's Development Finance Corporation (U.S. DFC) and Other Lenders to Expand Helium Plant Production Capacity Combined Company Expected to Target Cross-Sector Applications in Semiconductors, Quantum Computing, and Clean Energy DALLAS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (Nasdaq: ASPI) has successfull...

 PRESS RELEASE

ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquis...

ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited Positive progress in operations at Renergen’s Virginia Gas Project with a production update expected at the end of January 2026 WASHINGTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that all required regulatory approvals and clearances have been obtained for ASP Isotopes’ ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch